Daiichi Sankyo Is A Global Pharmaceutical Company Formed In 2005 From The Merger Of Daiichi Pharmaceutical Co Ltdand Sankyo Companylimitedwith A History Of Over 100 Yearsthe Company Has Made Significant Contributions To The Development Of Various Pharmaceuticals And Technologies Daiichi Sankyo Focuses On Creating Innovative Pharmaceuticals Across Multiple Therapeutic Areasincluding Cardiovascular Healthoncologyand Infectious Diseasesnotable Products Include Pravastatin For Cholesterol Managementolmesartan For Hypertensiontranexamic Acid To Prevent Excessive Bleedingticlopidine To Prevent Blood Clotslevofloxacin As A Broad Spectrum Antibioticand Azora Combination Drug For Lowering Blood Pressurethe Company Aims To Enhance Quality Of Life Globally Through Its Commitment To Research And Development And A Diverse Portfolio Of Healthcare Products
